Carbon Disulfide Neurotoxicity: Taiwan Experience

Acta Neurologica Taiwanica

Volumn 13, Issue 1, 2004, Pages 3-9

  Huang, Chin Chang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Carbon disulfide; Encephalopathy; Neurotoxicity; Parkinsonism; Peripheral neuropathy; Stroke

Indexed keywords

6 FLUORODOPA; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; CARBON DISULFIDE; XENON 133;

ATAXIA; ATHEROGENESIS; BRAIN DISEASE; CARDIOTOXICITY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC NERVE CELL; DRUG UPTAKE; ENVIRONMENTAL EXPOSURE; HALLUCINOSIS; HEART ARRHYTHMIA; HUMAN; HYPOREFLEXIA; INSOMNIA; LONG TERM EXPOSURE; MANIC DEPRESSIVE PSYCHOSIS; MEMORY DISORDER; MOOD DISORDER; MUSCLE ACTION POTENTIAL; MUSCLE STRENGTH; MYELINATION; NERVE CONDUCTION; NERVE POTENTIAL; NEUROFILAMENT; NEUROPATHOLOGY; NEUROTOXICITY; NIGHTMARE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; PARANOIA; PARESTHESIA; PARKINSONISM; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSORY DYSFUNCTION; SEXUAL DYSFUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLURRED SPEECH; SUICIDE; SUICIDE ATTEMPT; TAIWAN; TREMOR;

CARBON DISULFIDE; CARDIOVASCULAR SYSTEM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEUROTOXICITY SYNDROMES; PARKINSON DISEASE, SECONDARY; TAIWAN;

EID: 1842634950     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Allen N. Solvents and other industrial organic compounds. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology, vol 36. Amsterdam: Elsevier, North-Holland, Biochemical Press, 1979:382-6.
2. Verberk MM. Carbon disulfide. In: Vinken PJ, Bruyn GW, de Wolff FA, eds. Handbook of Clinical Neurology, vol 64. Amsterdam: Elsevier, North-Holland, Biochemical Press, 1994:23-9.
3. Graham DG, Valentine WM. Carbon disulfide. In: Spencer PS, Schaumburg HH, Ludolph R, eds. Experimental and Clinical Neurotoxicology. Oxford: Oxford University Press, 2000:315-7.
4. American Conference of Govenmental Industrial Hygienists. TLVs and BEIs: threshold limit values for chemical substances and physical agents; biological exposure indices. Cincinnati, Ohio: ACGIH. 2002.
5. National Institute for Occupational Safety and Health (NIOSH). 1994. Method 1600. In: NIOSH Manual of Analytical Methods. Eller PM, Cassinelli ME, eds. Cincinnati, Ohio: US Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Division of Physical Sciences and Engineering.
6. Occupational, Safety and Health Administration (OSHA). Occupational Safety and Health Standards for the Construction Industry. CFR. Code (29 CFR 1910.1000) of Federal regulations. Washington, DC: US Government. 1995.
7. Stetkiewicz J, Wronska-Nofer T. Updating of hygiene standards for carbon disulfide based on health, risk assessment. Int J Occup Med Environ Health 1998;11:129-43.
8. Vigliani EC. Carbon disulfide poisoning in viscose rayon factories. Br J Ind Med 1954;11:235-44.
9. Alpers BJ, Lewy FH. Changes in the nervous system following carbon disulfide poisoning in animals and in man. Arch Neurol Psychiatry 1940;44:725-39.
10. Lewey FH. Neurological, medical and biochemical signs and symptoms indicating chronic industrial carbon disulfide absorption. Ann Intern Med 1941;15:869-83.
11. Peters HA, Levine RL, Matthews CG, et al. Extrapyramidal and other neurological manifestations associated with carbon disulfide fumigant exposure. Arch Neurol 1988;45: 537-40.
12. Peters HA, Levine RL, Matthews CG, et al. Synergistic neurotoxicity of carbon tetrachloride/carbon disulfide (80/20 fumigants) and other pesticides in grain storage workers. Acta Pharmacol Toxicol 1986;59:535-46.
13. Peters HA, Levine RL, Matthews CG, et al. Carbon disulfide-induced neuropsychiatric changes in grain storage workers. Am J Ind Med 1982;3:373-91.
14. Toyamoa T, Sakurai H. Ten-year changes in exposure level and toxicological manifestations in carbon disulphide workers. In: Briefer H, Teisinger J, eds. Toxicology of Carbon Disulphide. Amsterdam: Excerpta Medica Foundation 1967:197-204.
15. Sepplinen AM, Haltia M. Carbon disulfide. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams & Wilkins, 1980;99:356-73.
16. Chu CC, Huang CC, Chen RS, et al. Carbon disulfide-induced polyneuropathy in viscose rayon workers. Occup Environ Med 1995;52:404-7.
17. Huang CC, Chu CC, Chen RS, et al. Chronic carbon disulfide encephalopathy. Eur Neurol 1996;36:364-8.
18. Manu P, Lilis R, Lancranjan J, et al. The value of electromyographic changes in the early diagnosis of carbon disulphide peripheral neuropathy. Med Lav 1970;61:102-8.
19. Seppalainen AM, Tolonen M. Neurotoxicity of long-term exposure to carbon disulfide in the viscose rayon industry. A neurophysiological study. Work Environ Health 1974;11: 145-53.
20. Vasilescu C. Sensory and motor conduction in chronic CS2 poisoning. Eur Neurol 1976;14:447-57.
21. Giglioli R, Bulgheroni C, Bertazzi PA, et al. Study of neurological and neurophysiological impairment in carbon disulphide workers. Med Lav 1978;69:130-43.
22. Vasilescu C, Florescu A. Clinical and electrophysiological studies of carbon disulfide polyneuropathy. J Neurol 1980;224:59-70.
23. Hirata M, Sugimoto K, Misumi J, et al. A neurophysiological study among Chinese CS2-exposed workers. G Ital Med Lav 1984;6:107-11.
24. Corsi G, Maestrelli P, Picitti G, et al. Chronic peripheral neuropathy in workers with previous exposure to carbon disulphide. Br J Ind Med 1983;40:209-11.
25. Chu CC, Huang CC, Chu NS, et al. Carbon disulfide induced polyneuropathy: sural nerve pathology, electrophysiology, and clinical correlation. Acta Neurol Scand 1996;94:258-63.
26. Juntunen J, Linnoila I, Haltia M. Histochemical and electron microscopic observation on the myoneural junctions of rats with carbon disulfide induced polyneuropathy. Scand J Work Environ Health 1977;3:36-42.
27. Colombi A, Maroni M, Picchi O, et al. Carbon disulfide neuropathy in rats. A morphological and ultrastructural study of degeneration and regeneration. Clin Toxicol 1981;18:1463-74.
28. Jirmanova I, Lukas E. Ultrastructure of carbon disulfide neuropathy. Acta Neuropathol (Berl) 1984;63:255-63.
29. Gottfried MR, Graham DG, Morgan M, et al. The morphology of carbon disulfide neurotoxicity. NeuroToxicology 1985;6:89-96.
30. Johnson DJ, Graham DG, Amarnath V, et al. Release of carbon disulfide is a contributing mechanism in the axonopathy produced by N, N-diethyldithiocarbamate. Toxicol Appl Pharmacol 1998;148:288-96.
31. Lehning EJ, Persaud A, Dyer KR, et al. Biochemical and morphologic characterization of acrylamide peripheral neuropathy. Toxicol Appl Pharmacol 1998;151:211-21.
32. Spencer PS, Schaumburg HH. Ultrastructural studies of the dying-back process III. The evaluation of experimental peripheral giant axon degeneration. J Neuropathol Exp Neurol 1977;36:276-99.
33. Graham DG, Amarnath V, Valentine WM, et al. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol 1995;25:91-112.
34. Huang CC, Chu CC, Wu TN, et al. Clinical course in patients with chronic carbon disulfide polyneuropathy. Clin Neurol Neurosurg 2002;104:115-20.
35. Aaserud O, Gjerstad L, Nakstad P, et al. Neurological examination, computerized tomography, cerebral blood flow and neuropsychological examination in workers with long term exposure to carbon disulfide. Toxicology 1988;49:277-82.
36. Aaserud O, Hommeren OJ, Tvedt B, et al. Carbon disulfide exposure and neurotoxic sequelae among viscose rayon workers. Am J Int Med 1990;18:25-37.
37. Aaserud O, Russell D, Nyberg-Hansen R, et al. Regional cerebral blood flow after long-term exposure to carbon disulfide. Acta Neurol Scand 1992;85:266-71.
38. Hanninen H. Psychological picture of manifest and latent carbon disulphide poisoning. Br J Ind Med 1971;28:374-81.
39. Richter RH. Degeneration of the basal ganglia in monkeys from chronic carbon disulfide poisoning. J Neuropathol Exp Neurol 1945;4:324-53.
40. Hua MS, Huang CC. Neuropsychological function in patients with chronic carbon disulfide intoxication. Acta Neurol Taiwan 2000;9:227-34.
41. Mena I, Horiuchi K, Burke K, et al. Chronic manganese poisoning: individual susceptibility and absorption of iron. Neurology 1969;19:1000-6.
42. Huang CC, Lu CC, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993;43:1479-83.
43. Huang CC, Chu CC, Chu NS, et al. Carbon disulfide vasculopathy: a small vessel disease. Cerebrovasc Dis 2001;11:245-50.
44. Sugimura, Kabashima K, Tatetsu S. Computerized tomography in chronic carbon disulfide poisoning. Brain Nerve (Tokyo) 1974;31:1245-53.
45. Cha JH, Kim SS, Han H, et al. Brain MRI findings of carbon disulfide poisoning. Korean J Radiol 2002;3:158-62.
46. Cho SK, Kim RH, Yim SH, et al. Long-term neuropsychological effects and MRI findings in patients with CS2 poisoning. Acta Neurol Scand 2002;106:269-75.
47. Ku MC, Huang CC, Kuo HC, et al. Diffuse white matter lesions in carbon disulfide intoxication: microangiopathy or demyelination. Eur Neurol 2003;50:220-4.
48. Hageman G, van der Hoek J, van Hout M, et al. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. J Neurol 1999;246:198-206.
49. Huang CC, Yen TC, Shih TS, et al. Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism. Neuro Toxicology 2004;25:341-7.
50. Huang CC, Weng YH, Lu CS, et al. Dopamine transporter binding in chronic manganese intoxication. J Neurol 2003; 250:1335-9.
51. Wojtczak-Jaroszowa J, Kubow S. Carbon monoxide, carbon disulfide, lead and cadmium-four examples of occupational toxic agents linked to cardiovascular disease. Med Hypoth 1989;30:141-50.
52. Partanen T, Hernberg S, Nordman CH, et al. Coronary heart disease among workers exposed to carbon disulphide. Br J Ind Med 1970;27:313-25.
53. Tolonen M. Vascular effects of carbon disulfide. A review. Scand J Work Environ Health 1975;1:63-77.
54. Hemberg S, Tolonen M, Nurminen M. Eight-year follow-up of viscose rayon workers exposed to carbon disulfide. Scand J Work Environ Health 1976;2:27-30.
55. Sweetnam PM, Taylor SW, Elwood PC. Exposure to carbon disulphide and ischaemic heart disease in a viscose rayon factory. Br J Ind Med 1987;44:220-7.
56. Tiller JR, Schilling RS, Morris JN. Occupational toxic factor in mortality from coronary heart disease. Br Med J 1968;4:407-11.
57. Nurminen M, Hernberg S. Effects of intervention on the cardiovascular mortality of workers exposed to carbon disulphide: a 15 year follow up. Br J Ind Med 1985;42:32-5.
58. Luo JC, Chang HY, Chang SJ, et al. Elevated triglyceride and decreased high density lipoprotein level in carbon disulfide workers in Taiwan. J Occup Environ Med 2003; 45:73-8.
59. Egeland GM, Burkhart GA, Schnorr TM, et al. Effects of exposure to carbon disulphide on low density lipoprotein cholesterol concentration and diastolic blood pressure. Br J Ind Med 1992;49:287-93.
60. Chandra SV, Butler WH, Magos L. The effect of carbon disulphide on the myocardium of the rat. Exp Mol Pathol 1972;17:249-59.
61. Wang VS, Lai TS, Lee CC, et al. Improved sampling and analytical method for airborne carbon disulfide measurement at workplace. Chromatographia 2001;54:383-8.
62. Chen CW, Shih TS, Li CC, et al. High performance liquid chromatographic determination of 2-thiothiazolidine-4-carboxylic acid as a marker of occupational exposure to carbon disulfide. Chromatographia 2001;53:665-8.
63. Drexler H, Goen T, Angerer J. Carbon disulphide. II. Investigations on the uptake of CS2 and the excretion of its metabolite 2-thiothiazolidine-4-carboxylic acid after occupational exposure. Int Arch Occup Environ Health 1995;67:5-10.
64. Rosier J, Veulemans H, Masschelein R, et al. Experimental human exposure to carbon disulfide. II. Urinary excretion of 2-thiothiazolidine-4-carboxylic acid (TTCA) during and after exposure. Int Arch Occup Enviro Health 1987;59:243-50.
65. Chang HY, Chou TC, Wang PY, et al. Biological monitoring of carbon disulphide: kinetics of urinary 2-thiothiazolidine-4-carboxylic acid (TTCA) in exposed workers. Toxicol Ind Health 2002;18:1-14.
66. Shih TS, Chou TC, Chang HY, et al. Accumulation of urinary 2-thiothiazolidine-4-carboxylic acid (TTCA) among the workers occupationally exposed to a-week-long exposure to carbon disulfide. Sci Total Environ 2003;308:37-47.
67. Chou TC, Shih TS, Sheu HM, et al. The effect of personal factors on the relationship between carbon disulfide exposure and urinary 2-thiothiazolidine-4-carboxylic acid levels in rayon manufacturing workers. Sci Total Environ (in press)